首页 | 本学科首页   官方微博 | 高级检索  
     


Toward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration
Authors:Ricardo Tejero  Eduardo Anitua  Gorka Orive
Affiliation:1. Department of Biochemistry and Molecular Biology, University of the Basque Country, 48940 Leioa, Spain;2. BTI I+D, Leonardo da Vinci 14B, 01510 Vitoria, Spain;3. Private Practice in Implantology and Oral Rehabilitation, José Mª Cagigal 19, 01007 Vitoria, Spain;4. Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, Vitoria, Spain;5. Networking Biomedical Research Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN, SLFPB-EHU, 01006 Vitoria-Gasteiz, Spain
Abstract:Replacing malfunctioning tissues with titanium-based implants has become a widespread practice spurred by population aging. Advances in biomaterials, technology and implantation protocols have led to increasing expectations on the applicability and durability of implants. The field has recently moved from a bioinert to a bioactive paradigm due to surface modifications that trigger specific responses on the surrounding tissues. Biopolymeric surface coatings have taken up a central role in these developments. The use of these and other biomimetic strategies on implants provides greater control over material–cell interactions and it is aimed at improving long-term clinical results by replicating some of the structures and mechanisms of living tissues. This review summarizes the state of the art of biomimetic implants and discusses the main directions and challenges of this field toward a more predictable and successful implant osseointegration.
Keywords:@w, at week   ADP, Adenosine DiPhosphate   AE, Acid Etched   ALP, Alkaline Phosphatase   APTES, (Aminopropyl)Triethoxysilane   ATP, Adenosin TriPhosphate   BIC, Bone-Implant Contact   BMP, Bone Morphogenetic Protein   BSP, Bone Sialoprotein   Ca, Calcium   CaP, Calcium Phosphate   CCL2, Chemokine Ligand 2   CD, Cluster of Differentiation   CDI, Carbonyldiimidazole   CoCr, Cobalt-Chrome   Col, Collagen   CS, Chondroitin Sulfate   CXCR, Chemokine Receptor   Cy5, Cyanine fluorescent dye (Excitation: 650 nm, Emission: 670 nm)   DEPPA, 3-(Diethoxy-Phosphoryl)propionicAcid   EC, Endothelial Cell   ECAD, Electrochemically Assisted Deposition   ECM, ExtraCellular Matrix   EDC, Ethyl(dimethylaminopropyl) Carbodiimide   Eph, Ephrin Receptor   FB, Fibroblast   FG, Fibrinogen   FGF, Fibroblastic Growth Factor   FITC, Fluorescein Isothiocyanate   FN, Fibronectin   GAG, Glycosaminoglycan   GDF, Growth and Differentiation Factor   GF, Growth Factor   Gly, Glycine   GP, Glycoprotein   GRGDSPC, Gly-Arg-Gly-Asp-Ser-Pro-Cys peptide sequence   HA, Hyaluronic Acid   HAP, Hydroxyapatite   HGF, Hepatocyte Growth Factor   HIF, Hypoxia-inducible Factor   HVP, Human Vitronectin Precursor   Hyl, Hydroxylysine   Hyp, Hydroxyproline   IGF, Insulin Growth Factor   IL, Interleukin   IPN, Interpenetrating Network   ISQ, Initial Stability Quotient   LN, Laminin   M-CSF, Macrophage Colony Stimulating Factor   Mach Ti, Titanium &ldquo  as machined&rdquo     MCP, Monocyte Chemotactic Protein   MMP, Matrix Metalloprotease   MSC, Mesenchymal Stem Cell   NCP, Non-Collagenous Protein   NFκβ, Nuclear Factor Kappa Beta   NHS, N-Hydroxysuccinimide   NPC, 4-Nitrophenil-Chloroformate   OB, Osteoblast   OC, Osteoclast   OCa, Osteocalcin   OCP, Octacalcium Phosphate   ON, Osteonectin   OPG, Osteoprotegerin   OPN, Osteopontin   Ox, Oxidized   p(OEGMA), Poly Oligo(Ethylene Glycol Methacrylate)   PA, Peri-Apatite   PAF, Platelet Activation Factor   PCCS, Platelet Concentrate Collection System   PCS, Platelet Collection System   PDGF, Platelet Derived Growth Factor   PEF, Platelet Enrichment Factor   PEG, Poly(Ethylene Glycol)   PG, Proteoglycan   PHSRN, Pro&ndash  His&ndash  Ser&ndash  Arg&ndash  Asn peptide sequence   PLT, Platelet   PMN, Polymorphonuclear leukocytes   PRGF, Plasma Rich in Growth Factors   Pro, Proline   PrP, Platelet rich Plasma   PS, Phosphoserine   PTH, Parathyroid Hormone   PVD, Plasma Vapor Deposition   RANK, Receptor Activator of Nuclear Factor   rBC, red Blood Cells   RGD, Arg-Lys-Asp peptide sequence   RGDC, Arg-Lys-Asp-Cys peptide sequence   SB, Sand Blasted   SBF, Simulated Body Fluid   SDF, Stromal Cell-Derived Factor   SMP, N-succimidyl-3-maleimidopropionate   SMPB, sulfo-Succinylimidyl-4-(p-Maleimido Phenyl Butyrate))   TCP, TriCalcium Phosphate   TGF-ß  , Transforming Growth Factor ß     Ti, Titanium   TIMP, Tissue Inhibitors of Metalloproteinases   TNF, Tumor Necrosis Factor   VEGF, Vascular Endothelial Growth Factor   VN, Vitronectin   vWF, von Willebrand Factor   wBC, white Blood Cells   μCT, Micro-Computer Tomography
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号